Imagine a patient named Arthur. He is 78 years old, lives alone, and takes seven different prescriptions daily. One morning, he wakes up feeling dizzy. He stumbles to the bathroom, falls, and breaks his hip. The hospital team reviews his chart and finds nothing wrong with his heart or balance muscles. The culprit? A common sleep aid prescribed for insomnia-a drug that, according to modern guidelines, should rarely be used in someone his age.
This scenario plays out thousands of times a year. It isn’t always bad luck; often, it’s a failure to recognize how aging changes the way our bodies handle medicine. This is where the Beers Criteria come in. They are not just a list of forbidden drugs; they are a vital roadmap for keeping older adults safe from medications that cause more harm than good.
What Are the Beers Criteria?
The Beers Criteria, formally known as the American Geriatrics Society (AGS) Beers Criteria® for Potentially Inappropriate Medication (PIM) Use in Older Adults, is an evidence-based guideline identifying drugs that pose higher risks than benefits for people aged 65 and older. Originally developed by Dr. Mark Beers and colleagues in 1991, these criteria address the physiological shifts that happen as we age. Your kidneys filter slower, your liver metabolizes differently, and your body composition changes. A dose that was fine at 40 can become toxic at 70.
Since 2011, the American Geriatrics Society has taken over updates. The most recent version, published in 2023, reviewed over 1,500 scientific articles. It serves two main purposes: helping doctors prescribe safely and acting as a quality metric for healthcare systems. However, the AGS is clear-they are not meant to be used punitively. As Todd Semla, co-chair of the expert panel, noted, they should never solely dictate prescribing decisions or justify restricting coverage.
The Five Pillars of the 2023 Update
The Beers Criteria don't just say "don't take this." They categorize risks into five distinct sections to help clinicians make nuanced decisions. Understanding these categories helps you spot potential issues in your own or a loved one's medication list.
- Medications to Avoid Regardless of Condition: These are drugs that generally offer little benefit but carry high risks for almost all older adults. Examples include certain anticholinergics and sedative-hypnotics like benzodiazepines.
- Medications to Avoid with Specific Diseases: Some drugs worsen specific conditions. For instance, non-steroidal anti-inflammatory drugs (NSAIDs) can exacerbate heart failure or kidney disease.
- Medications to Use with Caution: These aren't banned, but they require careful monitoring. Doses may need adjustment, or blood levels might need regular checking.
- Medications to Avoid with Renal Impairment: Since kidney function declines with age, many drugs need dose adjustments. The criteria specify which drugs to avoid when glomerular filtration rate (GFR) drops below certain thresholds.
- Clinically Significant Drug-Drug Interactions: Taking two seemingly harmless drugs together can create a dangerous effect. The criteria highlight pairs that should not be mixed.
| Category | Example Drug Class | Primary Risk in Older Adults |
|---|---|---|
| Sedatives/Hypnotics | Benzodiazepines (e.g., diazepam) | Falls, cognitive impairment, delirium |
| Anticholinergics | Diphenhydramine (Benadryl) | Confusion, constipation, urinary retention |
| Pain Relievers | NSAIDs (e.g., ibuprofen, naproxen) | Kidney damage, GI bleeding, hypertension |
| Diabetes Meds | Long-acting sulfonylureas (e.g., glyburide) | Hypoglycemia (low blood sugar), falls |
| Psychotropics | Typical antipsychotics (e.g., haloperidol) | Mortality risk in dementia patients |
Why Does This Matter? The Real-World Impact
You might think, "My doctor knows what they're doing." And usually, they do. But polypharmacy-the use of multiple medications-is incredibly common. About 40% of older adults take five or more medications, and roughly 20% are on at least one potentially inappropriate drug.
The consequences are serious. Studies show that PIMs defined by the Beers Criteria are linked to increased hospital admissions, functional decline, and even mortality. When a drug causes dizziness, an older adult might stop walking. When they stop walking, muscle mass decreases. Then, a simple trip leads to a fall. It’s a cascade effect that starts with a pill bottle.
The Beers Criteria act as a "warning light" on the dashboard, as Christine Holman, a clinical pharmacy specialist, describes them. They don't tell you exactly how to drive, but they alert you that something needs attention.
How to Use the Beers Criteria in Practice
If you are a clinician, integrating these criteria into your workflow is essential. If you are a patient or caregiver, understanding them empowers you to ask better questions. Here is how to apply this knowledge effectively.
For Clinicians: Beyond the Checklist
Don't just scan the list. Context matters. The 2023 update emphasizes that prescribing decisions are not always black and white. Consider the following steps:
- Check Renal Function: Always calculate creatinine clearance before prescribing drugs cleared by the kidneys.
- Review Interactions: Use electronic health record alerts, but verify them manually. Not every interaction is clinically significant for every patient.
- Deprescribe When Possible: If a drug is no longer needed or the risks outweigh the benefits, taper it off slowly. Sudden withdrawal can be dangerous.
- Use Shared Decision-Making: Discuss the pros and cons with the patient. Do they value sleep enough to risk a fall? Do they want aggressive cancer treatment if it means severe side effects?
For Patients and Caregivers: Questions to Ask
Bring a complete list of all medications-including over-the-counter drugs and supplements-to every appointment. Ask these specific questions:
- "Is this medication still necessary given my current health status?"
- "Are there safer alternatives with fewer side effects?"
- "Could any of my medicines be causing my dizziness or confusion?"
- "Do I need to adjust the dose because my kidney function has changed?"
Limitations and Criticisms
No tool is perfect. Critics argue that the Beers Criteria can be too simplistic. They might limit physician freedom or lead to defensive prescribing. For example, a patient with severe anxiety might genuinely need a short course of a benzodiazepine, despite the general warning. The criteria acknowledge this by stating that individual circumstances must be considered.
Furthermore, regulatory bodies like CMS have incorporated these metrics into nursing home assessments. While this improves overall safety, some worry it penalizes facilities for caring for complex patients who legitimately need high-risk medications under close supervision. The key is using the criteria as a guide for discussion, not a rigid rulebook.
Complementary Tools: STOPP-START and More
The Beers Criteria focus on what *not* to prescribe. But what about what *should* be prescribed? That’s where the STOPP-START criteria come in. Developed in Europe, this tool screens for both inappropriate prescriptions (STOPP) and potential omissions (START). Using both tools together provides a more comprehensive view of medication safety.
Additionally, the AGS offers the "5 Steps to Medication Review," a framework for managing multimorbidity. Combining these resources ensures you aren't just avoiding harm but also optimizing therapy.
Future Directions: Personalization and Technology
The future of medication safety lies in personalization. Pharmacogenomics-studying how genes affect drug response-is emerging as a critical factor. Two people might react differently to the same painkiller based on their DNA. Future updates to the Beers Criteria may integrate genetic data to refine recommendations further.
Technology also plays a role. Electronic health records are becoming smarter, offering real-time decision support. Imagine getting an alert not just for a drug interaction, but for a personalized risk assessment based on the patient's entire history. This integration will help frontline clinicians manage complexity without getting overwhelmed.
Who should use the Beers Criteria?
Primarily, healthcare providers such as physicians, pharmacists, and nurse practitioners caring for adults aged 65 and older. However, informed patients and caregivers can use simplified versions to discuss medication safety with their care teams.
Are the Beers Criteria legally binding?
No. They are clinical guidelines, not laws. While they influence insurance coverage and quality metrics, clinicians retain the authority to prescribe outside the criteria if justified by individual patient needs.
How often are the Beers Criteria updated?
The American Geriatrics Society typically updates the criteria every three to four years. The latest major update was published in 2023, incorporating evidence from 2019-2022.
Can I download the Beers Criteria for free?
Yes. The AGS provides a mobile app, pocket reference cards, and online access through GeriatricsCareOnline.org. Layperson guides are also available at healthinaging.org.
What is the difference between Beers Criteria and STOPP-START?
The Beers Criteria focus primarily on medications to avoid or use with caution in older adults. STOPP-START covers both inappropriate prescriptions (STOPP) and missing appropriate treatments (START), offering a broader perspective on medication optimization.
